Markus Bertini is listed as an executive officer on 1 SEC Form D filing by 1 issuer in Nov 2021: Endogena Therapeutics, Inc. (San Francisco, CA — industry reported as "Other" — 2021; $8M reported sold to 13 investors).
What this means One deal on file with the SEC, filed Nov 2021. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Aaron Weaver (1 shared filing), Daniel Zabrowski (1 shared filing), Elona Baum (1 shared filing) and Matthias Steger (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Markus. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Markus Bertini and found 1 difference: No amendment in the last 12 months on an offering that may still be open.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.